🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

18 results for “Hong Kong Baptist University” Clear

  1. CKD-495 75mg

    Hong Kong Baptist University

    Gastritis

    phase 3 small molecule completed

    1 trial

  2. CKD-501 0.5mg

    Hong Kong Baptist University

    Diabetes Mellitus, Type 2

    phase 3 small molecule completed

    2 trials

  3. A Master Ganoderma Detox Tea

    Hong Kong Baptist University

    Eczema

    phase 2 other active

    1 trial

  4. Ceftriaxone 1000mg + doxycycline 100 mg

    Hong Kong Baptist University

    Neisseria Gonorrhoeae Infection

    phase 2 small molecule completed

    1 trial

  5. MaZiRenWan (MZRW)

    Hong Kong Baptist University

    Functional Gastrointestinal Disorders

    phase 2 small molecule completed

    1 trial

  6. ZL-1102 1% w/w gel BID for 16 weeks

    Hong Kong Baptist University

    Plaque Psoriasis

    phase 2 small molecule active

    1 trial

  7. mutual support group

    Hong Kong Baptist University

    Schizophrenia

    phase 2 other completed

    1 trial

  8. CKD-371

    Hong Kong Baptist University

    Type II Diabetes Mellitus

    phase 1 small molecule completed

    1 trial

  9. CKD-381

    Hong Kong Baptist University

    GERD

    phase 1 small molecule completed

    1 trial

  10. CKD-393 formulation I

    Hong Kong Baptist University

    Type II Diabetes

    phase 1 small molecule completed

    1 trial

  11. CKD-581

    Hong Kong Baptist University

    Myeloma, Multiple

    phase 1 small molecule active

    1 trial

  12. glargine + exenatide

    Hong Kong Baptist University

    Type 2 Diabetes Mellitus

    approved small molecule completed

    1 trial

  13. Anvitra Gastric Suspension

    Hong Kong Baptist University

    GERD (Heartburn, Regurgitation, and Dyspepsia) Frequency

    other completed

    1 trial

  14. BioAmicus Complete

    Hong Kong Baptist University

    Infantile Colic

    other active

    1 trial

  15. Biolizin

    Hong Kong Baptist University

    Feeding and Eating Disorders of Childhood

    other active

    1 trial

  16. Prospan cough Syrup

    Hong Kong Baptist University

    Cough Severity

    small molecule completed

    1 trial

  17. Starch

    Hong Kong Baptist University

    Lens Opacity

    other completed

    1 trial

  18. trans-resveratrol

    Hong Kong Baptist University

    Eye Disease

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources